MYC and neoplasm: Contrast-enhanced MRI (CE-MRI) was performed before and 24 hours after administration of EPC2407 (20 mg/kg, i.v.)to assess changes in tumor perfusion following VDA treatment in subcutaneous (Figure 1A, 1B) and orthotopic (Figure 1C, 1D) Myc-CaP tumors.